EDX Medical Group Plc
Research EDX Medical Group Plc (EDX.L) on Bullrun: market cap GBX 3.77B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEDX.L
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyGBX
- Market capGBX 3.77B
- Financial periodFY2026
- RevenueGBP 330.54K
- Revenue growth169.6%
- Net income-GBP 5.76M
- Free cash flow-GBP 4.56M
- Gross margin-44.4%
Valuation Snapshot
latest market cap is GBX 3.77B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | GBP 330.54K | -GBP 5.76M | -GBP 4.56M | -44.4% | n/a | GBP 2.92M | GBP 77.80K | GBP 2.17M |
| FY2025 | GBP 122.61K | -GBP 3.59M | -GBP 3.67M | 24.0% | -0.01 | GBP 2.40M | GBP 129.39K | GBP 2.57M |
| FY2024 | GBP 227.99K | -GBP 3.75M | -GBP 3.19M | -9.1% | -0.01 | GBP 4.07M | GBP 1.42M | GBP 3.28M |
| FY2023 | GBP 3.86K | -GBP 3.71M | -GBP 1.28M | -0.8% | -0.01 | GBP 116.18K | GBP 1.93M | -GBP 952.68K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-04 | GBX 3.77B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBX.
About EDX Medical Group Plc
EDX Medical Group Plc, together with its subsidiaries, provides diagnostic products and solutions in the United Kingdom. It operates in two segments, Medical Goods and Medical Services. The company offers Caris MI Profile, a tumour profiling platform; cResponse, a platform the assess and predicts the effectiveness of single and multi drug chemotherapy; MI Tumor Seek, a next generation sequencing based tumour profiling service;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is EDX Medical Group Plc's market cap?
EDX Medical Group Plc's market capitalization is GBX 3.77B.
What does EDX Medical Group Plc do?
EDX Medical Group Plc, together with its subsidiaries, provides diagnostic products and solutions in the United Kingdom. It operates in two segments, Medical Goods and Medical Services.